<SEC-DOCUMENT>0001193125-14-057221.txt : 20140218
<SEC-HEADER>0001193125-14-057221.hdr.sgml : 20140217
<ACCEPTANCE-DATETIME>20140218165152
ACCESSION NUMBER:		0001193125-14-057221
CONFORMED SUBMISSION TYPE:	424B4
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20140218
DATE AS OF CHANGE:		20140218

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARCA biopharma, Inc.
		CENTRAL INDEX KEY:			0000907654
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				363855489
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-187508
		FILM NUMBER:		14622765

	BUSINESS ADDRESS:	
		STREET 1:		11080 CIRCLEPOINT ROAD
		STREET 2:		SUITE 140
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80020
		BUSINESS PHONE:		720-940-2200

	MAIL ADDRESS:	
		STREET 1:		11080 CIRCLEPOINT ROAD
		STREET 2:		SUITE 140
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80020

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVELO INC
		DATE OF NAME CHANGE:	20030203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HYSEQ INC
		DATE OF NAME CHANGE:	19970610
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B4
<SEQUENCE>1
<FILENAME>d679005d424b4.htm
<DESCRIPTION>424B4
<TEXT>
<HTML><HEAD>
<TITLE>424B4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prospectus Supplement No. 16</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>(to
Prospectus dated May&nbsp;30, 2013)</B></P></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed pursuant to Rule 424 (b)(4)</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration No. 333-187508</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>125,000 Shares of Series A Convertible Preferred Stock </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>12,500,000 Shares of Common Stock Underlying the Preferred Stock </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Warrants to Purchase up to 6,250,000 Shares of Common Stock and </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>6,250,000 Shares of Common Stock Underlying the Warrants </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g679005g13t01.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>ARCA biopharma, Inc. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement supplements the prospectus dated May&nbsp;30, 2013 (the &#147;Prospectus&#148;), as supplemented by that certain
Prospectus Supplement No.&nbsp;1 dated July&nbsp;17, 2013 (&#147;Supplement No.&nbsp;1&#148;), by that certain Prospectus Supplement No.&nbsp;2 dated July&nbsp;19, 2013 (&#147;Supplement No.&nbsp;2&#148;), by that certain Prospectus Supplement
No.&nbsp;3 dated July&nbsp;24, 2013 (&#147;Supplement No.&nbsp;3&#148;), by that certain Prospectus Supplement No.&nbsp;4 dated July&nbsp;30, 2013 (&#147;Supplement No.&nbsp;4&#148;), by that certain Prospectus Supplement No.&nbsp;5 dated
August&nbsp;6, 2013 (&#147;Supplement No.&nbsp;5&#148;), by that certain Prospectus Supplement No.&nbsp;6 dated September&nbsp;4, 2013 (&#147;Supplement No.&nbsp;6&#148;), by that certain Prospectus Supplement No.&nbsp;7 dated September&nbsp;23,
2013 (&#147;Supplement No.&nbsp;7&#148;), by that certain Prospectus Supplement No.&nbsp;8 dated October&nbsp;29, 2013 (&#147;Supplement No.&nbsp;8&#148;), by that certain Prospectus Supplement No.&nbsp;9 dated November&nbsp;6, 2013
(&#147;Supplement No.&nbsp;9&#148;), by that certain Prospectus Supplement No.&nbsp;10 dated November&nbsp;13, 2013 (&#147;Supplement No.&nbsp;10&#148;), by that certain Prospectus Supplement No.&nbsp;11 dated November&nbsp;21, 2013
(&#147;Supplement No.&nbsp;11&#148;), by that certain Prospectus Supplement No.&nbsp;12 dated December&nbsp;5, 2013 (&#147;Supplement No.&nbsp;12&#148;), by that certain Prospectus Supplement No.&nbsp;13 dated January&nbsp;8, 2014 (&#147;Supplement
No.&nbsp;13&#148;), by that certain Prospectus Supplement No.&nbsp;14 dated February&nbsp;10, 2014 (&#147;Supplement No.&nbsp;14&#148;), and by that certain Prospectus Supplement No.&nbsp;15 dated February&nbsp;12, 2014 (&#147;Supplement
No.&nbsp;15&#148;, and together with Supplement No.&nbsp;1, Supplement No.&nbsp;2, Supplement No.&nbsp;3, Supplement No.&nbsp;4, Supplement No.&nbsp;5, Supplement No.&nbsp;6, Supplement No.&nbsp;7, Supplement No.&nbsp;8, Supplement No.&nbsp;9,
Supplement No.&nbsp;10, Supplement No.&nbsp;11, Supplement No.&nbsp;12, Supplement No.&nbsp;13, and Supplement No.&nbsp;14, the &#147;Supplements&#148;), which form a part of our Registration Statement on Form S-1 (Registration No.&nbsp;333-187508).
This prospectus supplement is being filed to update and supplement the information in the Prospectus and the Supplements with the information contained in our current report on Form 8-K, filed with the Securities and Exchange Commission (the
&#147;Commission&#148;) on February&nbsp;18, 2014 (the &#147;Current Report&#148;). Accordingly, we have attached the Current Report to this prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Prospectus, the Supplements and this prospectus supplement relate to the offer and sale of up to 125,000 shares of Series A Convertible
Preferred Stock (&#147;Preferred Stock&#148;) which are convertible into 12,500,000 shares of Common Stock, warrants to purchase up to 6,250,000 shares of our Common Stock and 6,250,000 shares of Common Stock underlying the warrants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement should be read in conjunction with the Prospectus and the Supplements. This prospectus supplement updates and
supplements the information in the Prospectus and the Supplements. If there is any inconsistency between the information in the Prospectus, the Supplements and this prospectus supplement, you should rely on the information in this prospectus
supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is traded on the Nasdaq Global Market under the trading symbol &#147;ABIO.&#148; On February&nbsp;18, 2014,
the last reported sale price of our common stock was $1.79 per share. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman"><B>Investing in
our securities involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading &#147;Risk Factors&#148; beginning on page 5 of the Prospectus and beginning on page 23 of our quarterly report on
Form 10-Q for the quarterly period ended September&nbsp;30, 2013 before you decide whether to invest in shares of our common stock. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if the Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of
this prospectus supplement is February&nbsp;18, 2014 </B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): February&nbsp;18, 2014 (February 11, 2014) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>ARCA biopharma, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>000-22873</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>36-3855489</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of Incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>11080 CirclePoint Road, Suite 140, Westminster, CO 80020 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of Principal Executive Offices) (Zip Code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(720) 940-2200 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former
Name or Former Address, if Changed Since Last Report) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;11, 2014, the Board of Directors (the &#147;Board&#148;) of
ARCA biopharma, Inc. (the &#147;Company&#148;) elected Daniel J. Mitchell as a director of the Company to fill a vacancy on the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
connection with Mr.&nbsp;Mitchell&#146;s appointment, and pursuant to the Company&#146;s previously adopted director compensation policy, the Company granted Mr.&nbsp;Mitchell options to purchase (i)&nbsp;7,079 shares of common stock (&#147;Grant
1&#148;) and (ii)&nbsp;16,000 shares of common stock (&#147;Grant 2&#148;), each at an exercise price of $1.80 per share, the closing price of the Company&#146;s common stock on February&nbsp;11, 2014. The options are subject to the terms and
conditions of the Company&#146;s 2013 Equity Incentive Plan, as amended (the &#147;Plan&#148;), and the Company&#146;s standard forms of Stock Option Agreement and Option Grant Notice for the Plan, copies of which were filed as Exhibit 10.4 to the
Company&#146;s Current Report on Form 8-K filed on September&nbsp;23, 2013. The Grant 1 options vest in equal monthly installments over an eleven month period beginning February&nbsp;1, 2014, and the Grant 2 options vest in equal monthly
installments over a three year period beginning on the date of grant, in each case assuming Mr.&nbsp;Mitchell&#146;s continued service on the Board for such periods. On the same date, the Company also approved paying compensation to its existing
non-employee directors by granting to Dr.&nbsp;Linda Grais, Mr.&nbsp;Robert Conway and Dr.&nbsp;Raymond Woosley options to purchase 8,000 shares of common stock at an exercise price of $1.80 per share, the closing price of the Company&#146;s common
stock on February&nbsp;11, 2014. The options are subject to the terms and conditions of the Plan and the Company&#146;s standard forms of Stock Option Agreement and Option Grant Notice for the Plan. The options vest in equal monthly installments and
will be fully vested as of December&nbsp;31, 2014, assuming Dr.&nbsp;Grais&#146;, Mr.&nbsp;Conway&#146;s and Dr.&nbsp;Woosley&#146;s continued service on the Board for such periods. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;5.08. Shareholder Director Nominations. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February&nbsp;11, 2014, the Board approved June&nbsp;5, 2014 as the date of the Company&#146;s Annual Meeting of Stockholders (the
&#147;Annual Meeting&#148;). The Board also approved April&nbsp;7, 2014 as the record date for stockholders entitled to notice of and to vote at the Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because the Annual Meeting will be held more than 30 calendar days from the date of the Company&#146;s 2013 Annual Meeting of Stockholders,
the due dates for the provision of any qualified stockholder proposal or qualified stockholder nominations under the rules of the Securities and Exchange Commission (the &#147;SEC&#148;) and the bylaws of the Company listed in the Company&#146;s
2013 Proxy Statement on Schedule 14A as filed with the SEC on August&nbsp;1, 2013 are no longer applicable. Such nominations or proposals, including any notice on Schedule 14N, are now due to the Company no earlier than March&nbsp;7, 2014 and no
later than April&nbsp;6, 2014. The Company currently intends to make its proxy materials available beginning on or about April&nbsp;15, 2014. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: February&nbsp;18, 2014 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ARCA biopharma, Inc.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Registrant)</P></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher D. Ozeroff</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">Name: Christopher D. Ozeroff</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top">Title: SVP and General Counsel</TD></TR>
</TABLE></DIV>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g679005g13t01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g679005g13t01.jpg
M_]C_X0Y)17AI9@``34T`*@````@`"`$2``,````!``$```$:``4````!````
M;@$;``4````!````=@$H``,````!``(```$Q``(````>````?@$R``(````4
M````G`$[``(````1````L(=I``0````!````Q````/``+<;````G$``MQL``
M`"<0061O8F4@4&AO=&]S:&]P($-3-B`H5VEN9&]W<RD`,C`Q-#HP,CHQ."`R
M,SHP-CHT-@!*86-K:64@36ER;VYE<V-U```````#H`$``P````$``0``H`(`
M!`````$```"MH`,`!`````$````\``````````8!`P`#`````0`&```!&@`%
M`````0```3X!&P`%`````0```48!*``#`````0`"```"`0`$`````0```4X"
M`@`$`````0``#/,`````````2`````$```!(`````?_8_^T`#$%D;V)E7T--
M``'_[@`.061O8F4`9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48
M$Q,5$Q,8$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+
M"PT.#1`.#A`4#@X.%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`S_P``1"``W`*`#`2(``A$!`Q$!_]T`!``*_\0!
M/P```04!`0$!`0$``````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0``````
M```!``(#!`4&!P@)"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3
M(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T
M-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=7
M9W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!
MD12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T
M9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7
MI[?'_]H`#`,!``(1`Q$`/P#M.I=8R77NQL,^FVL[7V1+B[_@U69?U)XW#*L@
M>!"'36'WV2Z";'?]4M5M=5-8MOB7^R&1%H/[C1]%S5S\99^8R2G+).$!V+<(
MACB`(VTB[J<M'VFT2)F0A-ZAU2EP<+W6$?FO@M/]9;/I,>P.<TU;F!@>-=)^
MC'[RS\[&#-"!4!Q6#+OZST[-ASXXB<,LSXF<_P`D0E"1X3$.MT[.9G8[;@"Q
MW%C/!RMK'^K@BF\`R!9I]RUPM;E,LLF#'.6LI1U+7R1`F0&-]M=-3[K7;*JF
ME[W'@-:-SG?V5F?5?K]7U@Z4WJ#*S0[>^NRDG<6.:?;[OY=7IV?VU5^M-SLJ
MS`^KU4SU>TC*(,%N)2/5R_\`M[V8_P#UU<_]3KG=&^MG4_J_88JN<3CM/$U^
M^G_MW%=_X$K"Q[\K!ZU]9<[HKK+<GI-UO3ZW-:,RFRM^CM`ZR@EMM7O.U;PX
M6%]>H'U3ZE_Q;9_SV)*:^!];>H]5I.1TOH>1=0'%OJVW4T@ENCO3WO=O1>G_
M`%SP,CJ7[)SZ;NE=2G:W'R@-KR=6^AD5E]-F_P#,]R%_B[U^JU'AZMT?Y[US
MW^,1ASOK-TWI^"/5Z@ZH0QNKFGU`^JQ\?S;:XLL]1WT$E/H\B%B]9^MG2^D7
MLPW^IE]2MCTL#%;ZESI^CN;HRIO\JQR)]9>KNZ/T3(SF0Z]H%=`.LVO/IL_K
M;/IK`_Q<=(:,.[KV3-V=GV.`O<=SRP.VV/WN_P!/:W<])3J#J?URM:+*NBT4
MLY]._+_2$?\`6:7UL=_;0,3ZY9)ZW1T3JG2;NG9627"MYL;94X-!=OKL8&[V
MNA=.0(5'J/2<?J-F);82R[`O;D46-^D"/YRO7_!W,_1O24WF\:ZGQ0<W*JP\
M6[+N/Z+'K=:_X-&Y&G\>RYWZS3U/J&!]663Z69NR>HEO(Q:?HU_^A.2ZJK_M
MQ)3H?5SK5?7.D8_4FL](W`BRG=N-;P8=6YWM]RTQPN"^H>39T_K75/J]D?2%
MC[*0>-U?LLC_`(ZDTV+O6\)*?__0ZO&?%MAAI][M3I^<K^579;37;C`6FAQW
MMK;M!D?X/]_8LO(KLQ<RRJT1N>7-)TWM)W>U6J<X@;W&"UI;6!PV=''^LN<P
M9(Q,\.73B-:?U?TF[.)EPRCJW,?(R,@>E6QS1(+GN$`?YRAG6,<7"O83P6[8
M>".=ZA9G[P&.ES36`6D\.'YX_E*AE91>-UCM&B#8=-/Y:ES<Q$8N`$S\2MCC
MD961PNM]7C-60?\`A/X+6Y$+*Z!397B&VP%OKNWM!T]H'M_SE0^M/6\UF+E]
M,Z/AY65U*QAK#ZZG"JK>W^>-[MK';?\`@W+5Y&)'+8P11HZ'^\P9C>6==VET
MW]L=7ZUU'ZP],=C"EA_9V"[):]P-5+MV1;5Z3F;?6R=__;:R?KGC=8Z;U'`^
ML.4:'7,>UF[&:Y@+JR;&-M]5S]SKJO4J75_5"[&9TC'Z93CY&+9@TM9=5D5.
MK.[_``C@]P].W?9O?^C<JOUYLHR>E7=*;BY&7FO:VW%;14YX#VN]C_5_F6_V
MWJRQO0XF53EXU652[=5D,;96?)PW!8_UZ_\`$GU*/]&W_JV+'^J76.H=*P:N
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M;_/)*>\E,7-`+B0`.3V"Q*_KC]7WLE^0^E_#JK:;6V-/[KV&M8G7NI]4^L8K
MZ/TOIV6WI>5:RO.ZA;6:@:=TV,H99LM]-[?YR[;]!)3VI>S;.X;8W;ITC]Z5
MQW0AUOJF9G_67IK\5M/4+!1BG)8]SABXVZMGI>D]FS[1;ZEKF(_ULZOF.Z=E
M=%Z%@9>1DN;]G?=54154PC;9LM?M;99Z?LK]-:OU;R<-W3:L/$HNQ1@L92ZG
M(J=46D-_E@-L_KUI*>+^L]?5.A_6#`Z_E&DVVN!L=C!S&D5>VYCQ8YSG.NQK
M/_`UZ359796VVLRRQH>UP[APEI7*?7U]>=TVSI=.)DY?4&.KNQVTU.<T&=7>
MO'I?S7J>W>A?5;KF;T_I]/2^M=.S<=V.-F/DFEUC7LG]&UYJW^G;7]#WI*?_
MT?3<C#Q\EH;D5ML`XGD?U7*M^PNF<>E_TBM"$H44\&*9N<(S/>0M<)$:`EH'
MH?3?]&?\X_WIV=&Z=6X/;2"X&1N)<)\=I5Z$H31RN`&QB@/\&*N.7<L0"/[D
M#-S:\+'-]H<YH(;#!)EQVL_SG*R5D]0L.1U&C$9`9C#[3D/<?:PZ^BZS^K_.
M;%.M=1I+@"X08!+>X*%7E569-N*P.#Z`TN)!#3N_<?\`GJM@9-[\!U][VN@O
M<RYXV!U;?HW/:U-A9=PZ;9FYCCL)=:QI:&N;5_@V%O\`*24Z$^:4D:?BLBG,
MSO7P1?H_.WN?C`"*ZPW<WW_O-]F]$ZB'Y74<;!#BRI@^U6/9HX;#MJ'[NUSR
MDIT]>Q5;%S:\FV^NMKV_9G>F][A$NY.U5^G=0>_I'V_+<(8+'.L`@.8QSMEF
MW^4QJI8QZAC8F&\.#+\N_?900'%XM/J6V/\`SOT3/W/YO\])3O3YI:<CYJID
MYFR[T*RT/:/4NL=]&NL?GN_X1W^#:A]-MRLFFS*L=N;<XG%8\;8K;[6.=M_T
MO\XDIOSW\$N_*R<&[J6=6^UF0*Z6WGTK/3!-E;3M>S;^:S=]"SZ:)G9.6W/Q
ML7%<V;";+&$2!4/IV6N_-;^YM24Z7ST26"SJ'4;:2:;I^T9.S!<6B7L:?TUC
MV_FX[?S7_P`XM7*R34YE-3?4R+B16P_1$?3NM_=JK24V9'$IQ*SNG7Y&5D9%
MOJ;\1A%5.@`>YO\`/VB/\'O]E:T0(\_-)3__TO54E\JI)*?JI)?*J22GZI*S
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MMR&#[2=X#F5`0(_T-6W<OF5))3],#$Z6;L>\6@!E.RBH/&PUZ>]K?SOZZ)DX
MF%;EMNMM+;65.:ZL/VAU1^GZC/I>FUWYR^8TDE/T]TW'Q,>AM>+9ZK`T;7[@
M\[9.W5OYG[JN+Y5224__V?_M%GI0:&]T;W-H;W`@,RXP`#A"24T$!```````
M)!P!6@`#&R5''`(```((>!P"4``02F%C:VEE($UI<F]N97-C=3A"24T$)0``
M````$,BE$DH4QMH,!T>N%OJ%"%@X0DE-!#H``````14````0`````0``````
M"W!R:6YT3W5T<'5T````!0````!0<W138F]O;`$`````26YT965N=6T`````
M26YT90````!#;')M````#W!R:6YT4VEX=&5E;D)I=&)O;VP`````"W!R:6YT
M97).86UE5$585````!D`4@!I`&,`;P!H`"``00!F`&D`8P!I`&\`(`!-`%``
M(``V`#4`,``P`"``4`!#`$P```````]P<FEN=%!R;V]F4V5T=7!/8FIC````
M#`!0`'(`;P!O`&8`(`!3`&4`=`!U`'````````IP<F]O9E-E='5P`````0``
M``!";'1N96YU;0````QB=6EL=&EN4')O;V8````)<')O;V9#35E+`#A"24T$
M.P`````"+0```!`````!```````2<')I;G1/=71P=71/<'1I;VYS````%P``
M``!#<'1N8F]O;```````0VQB<F)O;VP``````%)G<TUB;V]L``````!#<FY#
M8F]O;```````0VYT0V)O;VP``````$QB;'-B;V]L``````!.9W1V8F]O;```
M````16UL1&)O;VP``````$EN=')B;V]L``````!"8VMG3V)J8P````$`````
M``!21T)#`````P````!29"`@9&]U8D!OX````````````$=R;B!D;W5B0&_@
M````````````0FP@(&1O=6)`;^````````````!"<F1456YT1B-2;'0`````
M``````````!";&0@56YT1B-2;'0```````````````!2<VQT56YT1B-0>&Q`
M<L````````````IV96-T;W)$871A8F]O;`$`````4&=0<V5N=6T`````4&=0
M<P````!09U!#`````$QE9G15;G1&(U)L=````````````````%1O<"!5;G1&
M(U)L=````````````````%-C;"!5;G1&(U!R8T!9````````````$&-R;W!7
M:&5N4')I;G1I;F=B;V]L``````YC<F]P4F5C=$)O='1O;6QO;F<`````````
M#&-R;W!296-T3&5F=&QO;F<`````````#6-R;W!296-T4FEG:'1L;VYG````
M``````MC<F]P4F5C=%1O<&QO;F<``````#A"24T#[0``````$`$L`````0`"
M`2P````!``(X0DE-!"8```````X`````````````/X```#A"24T$#0``````
M!````'@X0DE-!!D```````0````>.$))30/S```````)```````````!`#A"
M24TG$```````"@`!``````````(X0DE-`_4``````$@`+V9F``$`;&9F``8`
M``````$`+V9F``$`H9F:``8```````$`,@````$`6@````8```````$`-0``
M``$`+0````8```````$X0DE-`_@``````'```/______________________
M______\#Z`````#_____________________________`^@`````________
M_____________________P/H`````/____________________________\#
MZ```.$))300(```````0`````0```D````)``````#A"24T$'@``````!```
M```X0DE-!!H``````WT````&```````````````\````K0```"0`0@!!`#0`
M.0`T`#D`-P`T`#4`,``U`#8`.`!!`#,`0@`U`$,`.0!%`#$`,P`Q`$8`-@`U
M`$(`.``Q`$,`10`V`%\`,0`M`#$````!``````````````````````````$`
M`````````````*T````\``````````````````````$`````````````````
M````````$`````$```````!N=6QL`````@````9B;W5N9'-/8FIC`````0``
M`````%)C=#$````$`````%1O<"!L;VYG``````````!,969T;&]N9P``````
M````0G1O;6QO;F<````\`````%)G:'1L;VYG````K0````9S;&EC97-6;$QS
M`````4]B:F,````!```````%<VQI8V4````2````!W-L:6-E241L;VYG````
M``````=G<F]U<$E$;&]N9P`````````&;W)I9VEN96YU;0````Q%4VQI8V5/
M<FEG:6X````-875T;T=E;F5R871E9`````!4>7!E96YU;0````I%4VQI8V54
M>7!E`````$EM9R`````&8F]U;F1S3V)J8P````$```````!28W0Q````!```
M``!4;W`@;&]N9P``````````3&5F=&QO;F<``````````$)T;VUL;VYG````
M/`````!29VAT;&]N9P```*T````#=7)L5$585`````$```````!N=6QL5$58
M5`````$```````!-<V=E5$585`````$```````9A;'1486=415A4`````0``
M````#F-E;&Q497AT27-(5$U,8F]O;`$````(8V5L;%1E>'1415A4`````0``
M````"6AO<GI!;&EG;F5N=6T````/15-L:6-E2&]R>D%L:6=N````!V1E9F%U
M;'0````)=F5R=$%L:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F
M875L=`````MB9T-O;&]R5'EP965N=6T````115-L:6-E0D=#;VQO<E1Y<&4`
M````3F]N90````ET;W!/=71S971L;VYG``````````IL969T3W5T<V5T;&]N
M9P`````````,8F]T=&]M3W5T<V5T;&]N9P`````````+<FEG:'1/=71S971L
M;VYG```````X0DE-!"@```````P````"/_`````````X0DE-!!0```````0`
M```".$))300,``````T/`````0```*`````W```!X```9R````SS`!@``?_8
M_^T`#$%D;V)E7T--``'_[@`.061O8F4`9(`````!_]L`A``,"`@("0@,"0D,
M$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.%!0.#@X.%!$,#`P,#!$1#`P,#`P,
M$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"``W`*`#`2(``A$!
M`Q$!_]T`!``*_\0!/P```04!`0$!`0$``````````P`!`@0%!@<("0H+`0`!
M!0$!`0$!`0`````````!``(#!`4&!P@)"@L0``$$`0,"!`(%!P8(!0,,,P$`
M`A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46
MHK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F
M=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`"$0,A
M,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8U
MPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:V
MQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1`Q$`/P#M.I=8R77NQL,^FVL[7V1+
MB[_@U69?U)XW#*L@>!"'36'WV2Z";'?]4M5M=5-8MOB7^R&1%H/[C1]%S5S\
M99^8R2G+).$!V+<(ACB`(VTB[J<M'VFT2)F0A-ZAU2EP<+W6$?FO@M/]9;/I
M,>P.<TU;F!@>-=)^C'[RS\[&#-"!4!Q6#+OZST[-ASXXB<,LSXF<_P`D0E"1
MX3$.MT[.9G8[;@"QW%C/!RMK'^K@BF\`R!9I]RUPM;E,LLF#'.6LI1U+7R1`
MF0&-]M=-3[K7;*JFE[W'@-:-SG?V5F?5?K]7U@Z4WJ#*S0[>^NRDG<6.:?;[
MOY=7IV?VU5^M-SLJS`^KU4SU>TC*(,%N)2/5R_\`M[V8_P#UU<_]3KG=&^MG
M4_J_88JN<3CM/$U^^G_MW%=_X$K"Q[\K!ZU]9<[HKK+<GI-UO3ZW-:,RFRM^
MCM`ZR@EMM7O.U;PX6%]>H'U3ZE_Q;9_SV)*:^!];>H]5I.1TOH>1=0'%OJVW
M4T@ENCO3WO=O1>G_`%SP,CJ7[)SZ;NE=2G:W'R@-KR=6^AD5E]-F_P#,]R%_
MB[U^JU'AZMT?Y[USW^,1ASOK-TWI^"/5Z@ZH0QNKFGU`^JQ\?S;:XLL]1WT$
ME/H\B%B]9^MG2^D7LPW^IE]2MCTL#%;ZESI^CN;HRIO\JQR)]9>KNZ/T3(SF
M0Z]H%=`.LVO/IL_K;/IK`_Q<=(:,.[KV3-V=GV.`O<=SRP.VV/WN_P!/:W<]
M)3J#J?URM:+*NBT4LY]._+_2$?\`6:7UL=_;0,3ZY9)ZW1T3JG2;NG9627"M
MYL;94X-!=OKL8&[VNA=.0(5'J/2<?J-F);82R[`O;D46-^D"/YRO7_!W,_1O
M24WF\:ZGQ0<W*JP\6[+N/Z+'K=:_X-&Y&G\>RYWZS3U/J&!]663Z69NR>HEO
M(Q:?HU_^A.2ZJK_MQ)3H?5SK5?7.D8_4FL](W`BRG=N-;P8=6YWM]RTQPN"^
MH>39T_K75/J]D?2%C[*0>-U?LLC_`(ZDTV+O6\)*?__0ZO&?%MAAI][M3I^<
MK^579;37;C`6FAQWMK;M!D?X/]_8LO(KLQ<RRJT1N>7-)TWM)W>U6J<X@;W&
M"UI;6!PV=''^LN<P9(Q,\.73B-:?U?TF[.)EPRCJW,?(R,@>E6QS1(+GN$`?
MYRAG6,<7"O83P6[8>".=ZA9G[P&.ES36`6D\.'YX_E*AE91>-UCM&B#8=-/Y
M:ES<Q$8N`$S\2MCCD961PNM]7C-60?\`A/X+6Y$+*Z!397B&VP%OKNWM!T]H
M'M_SE0^M/6\UF+E],Z/AY65U*QAK#ZZG"JK>W^>-[MK';?\`@W+5Y&)'+8P1
M1HZ'^\P9C>6==VETW]L=7ZUU'ZP],=C"EA_9V"[):]P-5+MV1;5Z3F;?6R=_
M_;:R?KGC=8Z;U'`^L.4:'7,>UF[&:Y@+JR;&-M]5S]SKJO4J75_5"[&9TC'Z
M93CY&+9@TM9=5D5.K.[_``C@]P].W?9O?^C<JOUYLHR>E7=*;BY&7FO:VW%;
M14YX#VN]C_5_F6_VWJRQO0XF53EXU652[=5D,;96?)PW!8_UZ_\`$GU*/]&W
M_JV+'^J76.H=*P:NE=7Z;F45U.VXN2*7/86O=(JO]/>ZIU;G?SG\VK7USZD_
M*Z;F=$P<++R\RW:PFJEWIL$MM-GKO#:W[8_,<DIR_JYT;J6=]4FY/2^HY.%F
M[K?2J8\"@EKW?HS4YOM]7_2_OHG^+KJ.'ZN5@Y-/I=;<YS[<JWW7WAKOTM=]
MK_?Z^(_VNJ^AL_2*U]2\^WIF!3T;J.!EXN0;G!ECZ7&IWJ.-C7>LS>VO_KBJ
M?7;ZNYU'4:?K#T-CSDFQOVAE#=SFVM]M62U@^DRQGZ#,_D)*=7_&)2^WZLO>
MR8HNJM?'9H.TN_L[]Z+]0<BJ[ZKXK6\X[GTO'@YKRYT_YR+TWK;>JUMZ?U3I
MN3A9&2QS;J+ZG&D@C])MR&37M>W]_P!ZP<7I77OJ7U"VWIU%G6.AY)!MIK(^
MT5[?YMS*Y_2OK;[/;_/)*>\E,7-`+B0`.3V"Q*_KC]7WLE^0^E_#JK:;6V-/
M[KV&M8G7NI]4^L8KZ/TOIV6WI>5:RO.ZA;6:@:=TV,H99LM]-[?YR[;]!)3V
MI>S;.X;8W;ITC]Z5QW0AUOJF9G_67IK\5M/4+!1BG)8]SABXVZMGI>D]FS[1
M;ZEKF(_ULZOF.Z=E=%Z%@9>1DN;]G?=54154PC;9LM?M;99Z?LK]-:OU;R<-
MW3:L/$HNQ1@L92ZG(J=46D-_E@-L_KUI*>+^L]?5.A_6#`Z_E&DVVN!L=C!S
M&D5>VYCQ8YSG.NQK/_`UZ359796VVLRRQH>UP[APEI7*?7U]>=TVSI=.)DY?
M4&.KNQVTU.<T&=7>O'I?S7J>W>A?5;KF;T_I]/2^M=.S<=V.-F/DFEUC7LG]
M&UYJW^G;7]#WI*?_T?3<C#Q\EH;D5ML`XGD?U7*M^PNF<>E_TBM"$H44\&*9
MN<(S/>0M<)$:`EH'H?3?]&?\X_WIV=&Z=6X/;2"X&1N)<)\=I5Z$H31RN`&Q
MB@/\&*N.7<L0"/[D#-S:\+'-]H<YH(;#!)EQVL_SG*R5D]0L.1U&C$9`9C#[
M3D/<?:PZ^BZS^K_.;%.M=1I+@"X08!+>X*%7E569-N*P.#Z`TN)!#3N_<?\`
MGJM@9-[\!U][VN@O<RYXV!U;?HW/:U-A9=PZ;9FYCCL)=:QI:&N;5_@V%O\`
M*24Z$^:4D:?BLBG,SO7P1?H_.WN?C`"*ZPW<WW_O-]F]$ZB'Y74<;!#BRI@^
MU6/9HX;#MJ'[NUSRDIT]>Q5;%S:\FV^NMKV_9G>F][A$NY.U5^G=0>_I'V_+
M<(8+'.L`@.8QSMEFW^4QJI8QZAC8F&\.#+\N_?900'%XM/J6V/\`SOT3/W/Y
MO\])3O3YI:<CYJIDYFR[T*RT/:/4NL=]&NL?GN_X1W^#:A]-MRLFFS*L=N;<
MXG%8\;8K;[6.=M_TO\XDIOSW\$N_*R<&[J6=6^UF0*Z6WGTK/3!-E;3M>S;^
M:S=]"SZ:)G9.6W/QL7%<V;";+&$2!4/IV6N_-;^YM24Z7ST26"SJ'4;:2:;I
M^T9.S!<6B7L:?TUCV_FX[?S7_P`XM7*R34YE-3?4R+B16P_1$?3NM_=JK24V
M9'$IQ*SNG7Y&5D9%OJ;\1A%5.@`>YO\`/VB/\'O]E:T0(\_-)3__TO54E\JI
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M^4/I*M;A]/<_,#[8MR&#[2=X#F5`0(_T-6W<OF5))3],#$Z6;L>\6@!E.RBH
M/&PUZ>]K?SOZZ)DXF%;EMNMM+;65.:ZL/VAU1^GZC/I>FUWYR^8TDE/T]TW'
MQ,>AM>+9ZK`T;7[@\[9.W5OYG[JN+Y5224__V0`X0DE-!"$``````%4````!
M`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````3`$$`9`!O
M`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``0P!3`#8````!`#A"24T$!@``
M````!P`(`````0$`_^$.76AT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\`
M/#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C
M>FMC.60B/SX@/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@
M>#IX;7!T:STB061O8F4@6$U0($-O<F4@-2XS+6,P,3$@-C8N,30U-C8Q+"`R
M,#$R+S`R+S`V+3$T.C4V.C(W("`@("`@("`B/B`\<F1F.E)$1B!X;6QN<SIR
M9&8](FAT='`Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN
M<R,B/B`\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7`]
M(FAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B('AM;&YS.G!D9CTB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(@>&UL;G,Z9&,](FAT='`Z+R]P
M=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(B!X;6QN<SIX;7!-33TB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87`O,2XP+VUM+R(@>&UL;G,Z<W1%=G0](FAT='`Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT(R(@
M>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N8V]M+W!H;W1O<VAO
M<"\Q+C`O(B!X;7`Z0W)E871E1&%T93TB,C`Q-"TP,BTQ.%0R,SHP-3HT,B(@
M>&UP.D-R96%T;W)4;V]L/2)-:6-R;W-O9G3"KB!/9F9I8V4@5V]R9"`R,#`W
M(B!X;7`Z36]D:69Y1&%T93TB,C`Q-"TP,BTQ.%0R,SHP-CHT-BLP-3HS,"(@
M>&UP.DUE=&%D871A1&%T93TB,C`Q-"TP,BTQ.%0R,SHP-CHT-BLP-3HS,"(@
M<&1F.E!R;V1U8V5R/2)-:6-R;W-O9G3"KB!/9F9I8V4@5V]R9"`R,#`W(B!D
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M,BXQ(CX@/&1C.F-R96%T;W(^(#QR9&8Z4V5Q/B`\<F1F.FQI/DIA8VMI92!-
M:7)O;F5S8W4\+W)D9CIL:3X@/"]R9&8Z4V5Q/B`\+V1C.F-R96%T;W(^(#QX
M;7!-33I(:7-T;W)Y/B`\<F1F.E-E<3X@/')D9CIL:2!S=$5V=#IA8W1I;VX]
M(F1E<FEV960B('-T179T.G!A<F%M971E<G,](F-O;G9E<G1E9"!F<F]M(&%P
M<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W`@=&\@:6UA9V4O:G!E9R(O
M/B`\<F1F.FQI('-T179T.F%C=&EO;CTB<V%V960B('-T179T.FEN<W1A;F-E
M240](GAM<"YI:60Z.4$V1#=$,49#,CDX13,Q,4(P0C="13E&0C4X.#4X,D(B
M('-T179T.G=H96X](C(P,30M,#(M,3A4,C,Z,#8Z-#8K,#4Z,S`B('-T179T
M.G-O9G1W87)E06=E;G0](D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I
M(B!S=$5V=#IC:&%N9V5D/2(O(B\^(#PO<F1F.E-E<3X@/"]X;7!-33I(:7-T
M;W)Y/B`\>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B+SX@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO<F1F.E)$1CX@/"]X.GAM<&UE
M=&$^("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@/#]X<&%C:V5T(&5N9#TB=R(_
M/O_B#%A)0T-?4%)/1DE,10`!`0``#$A,:6YO`A```&UN=')21T(@6%E:(`?.
M``(`"0`&`#$``&%C<W!-4T94`````$E%0R!S4D="```````````````!``#V
MU@`!`````-,M2%`@(```````````````````````````````````````````
M````````````````````$6-P<G0```%0````,V1E<V,```&$````;'=T<'0`
M``'P````%&)K<'0```($````%')865H```(8````%&=865H```(L````%&)8
M65H```)`````%&1M;F0```)4````<&1M9&0```+$````B'9U960```-,````
MAG9I97<```/4````)&QU;6D```/X````%&UE87,```0,````)'1E8V@```0P
M````#')44D,```0\```(#&=44D,```0\```(#&)44D,```0\```(#'1E>'0`
M````0V]P>7)I9VAT("AC*2`Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY
M``!D97-C`````````!)S4D="($E%0S8Q.38V+3(N,0``````````````$G-2
M1T(@245#-C$Y-C8M,BXQ````````````````````````````````````````
M``````````````````````````!865H@````````\U$``0````$6S%A96B``
M````````````````````6%E:(````````&^B```X]0```Y!865H@````````
M8ID``+>%```8VEA96B`````````DH```#X0``+;/9&5S8P`````````6245#
M(&AT='`Z+R]W=W<N:65C+F-H```````````````6245#(&AT='`Z+R]W=W<N
M:65C+F-H````````````````````````````````````````````````````
M`````````&1E<V,`````````+DE%0R`V,3DV-BTR+C$@1&5F875L="!21T(@
M8V]L;W5R('-P86-E("T@<U)'0@``````````````+DE%0R`V,3DV-BTR+C$@
M1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@``````````````````
M``````````!D97-C`````````"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I
M;VX@:6X@245#-C$Y-C8M,BXQ```````````````L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``````````````````````
M````````````=FEE=P``````$Z3^`!1?+@`0SQ0``^W,``03"P`#7)X````!
M6%E:(```````3`E6`%````!7'^=M96%S``````````$`````````````````
M```````"CP````)S:6<@`````$-25"!C=7)V````````!``````%``H`#P`4
M`!D`'@`C`"@`+0`R`#<`.P!``$4`2@!/`%0`60!>`&,`:`!M`'(`=P!\`($`
MA@"+`)``E0":`)\`I`"I`*X`L@"W`+P`P0#&`,L`T`#5`-L`X`#E`.L`\`#V
M`/L!`0$'`0T!$P$9`1\!)0$K`3(!.`$^`44!3`%2`5D!8`%G`6X!=0%\`8,!
MBP&2`9H!H0&I`;$!N0'!`<D!T0'9`>$!Z0'R`?H"`P(,`A0"'0(F`B\".`)!
M`DL"5`)=`F<"<0)Z`H0"C@*8`J("K`*V`L$"RP+5`N`"ZP+U`P`#"P,6`R$#
M+0,X`T,#3P-:`V8#<@-^`XH#E@.B`ZX#N@/'`],#X`/L`_D$!@03!"`$+00[
M!$@$501C!'$$?@2,!)H$J`2V!,0$TP3A!/`$_@4-!1P%*P4Z!4D%6`5G!7<%
MA@66!:8%M07%!=4%Y07V!@8&%@8G!C<&2`99!FH&>P:,!IT&KP;`!M$&XP;U
M!P<'&0<K!ST'3P=A!W0'A@>9!ZP'OP?2!^4'^`@+"!\(,@A&"%H(;@B"")8(
MJ@B^"-((YPC["1`))0DZ"4\)9`EY"8\)I`FZ"<\)Y0G["A$*)PH]"E0*:@J!
M"I@*K@K%"MP*\PL+"R(+.0M1"VD+@`N8"[`+R`OA"_D,$@PJ#$,,7`QU#(X,
MIPS`#-D,\PT-#28-0`U:#70-C@VI#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.T@[N
M#PD/)0]!#UX/>@^6#[,/SP_L$`D0)A!#$&$0?A";$+D0UQ#U$1,1,1%/$6T1
MC!&J$<D1Z!('$B8211)D$H02HQ+#$N,3`Q,C$T,38Q.#$Z03Q1/E%`84)Q1)
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M-"LT932>--@U$S5--8<UPC7]-C<V<C:N-NDW)#=@-YPWUS@4.%`XC#C(.04Y
M0CE_.;PY^3HV.G0ZLCKO.RT[:SNJ.^@\)SQE/*0\XSTB/6$]H3W@/B`^8#Z@
M/N`_(3]A/Z(_XD`C0&1`ID#G02E!:D&L0>Y",$)R0K5"]T,Z0WU#P$0#1$=$
MBD3.11)%546:1=Y&(D9G1JM&\$<U1WM'P$@%2$M(D4C721U)8TFI2?!*-TI]
M2L1+#$M32YI+XDPJ3'),NDT"34I-DTW<3B5.;DZW3P!/24^33]U0)U!Q4+M1
M!E%049M1YE(Q4GQ2QU,34U]3JE/V5$)4CU3;52A5=57"5@]67%:I5O=71%>2
M5^!8+UA]6,M9&EEI6;A:!UI66J9:]5M%6Y5;Y5PU7(9<UETG77A=R5X:7FQ>
MO5\/7V%?LV`%8%=@JF#\84]AHF'U8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G
M9CUFDF;H9SUGDV?I:#]HEFCL:4-IFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!M
MN6X2;FMNQ&\>;WAOT7`K<(9PX'$Z<95Q\')+<J9S`7-=<[AT%'1P=,QU*'6%
M=>%V/G:;=OAW5G>S>!%X;GC,>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^
M`7YB?L)_(W^$?^6`1X"H@0J!:X'-@C""DH+T@U>#NH0=A("$XX5'A:N&#H9R
MAM>'.X>?B`2(:8C.B3.)F8G^BF2*RHLPBY:+_(QCC,J-,8V8C?^.9H[.CS:/
MGI`&D&Z0UI$_D:B2$9)ZDN.339.VE""4BI3TE5^5R98TEI^7"I=UE^"83)BX
MF229D)G\FFB:U9M"FZ^<')R)G/>=9)W2GD">KI\=GXN?^J!IH-BA1Z&VHB:B
MEJ,&HW:CYJ16I,>E.*6IIAJFBZ;]IVZGX*A2J,2I-ZFIJARJCZL"JW6KZ:Q<
MK-"M1*VXKBVNH:\6KXNP`+!UL.JQ8+'6LDNRPK,XLZZT);2<M1.UBK8!MGFV
M\+=HM^"X6;C1N4JYPKH[NK6[+KNGO"&\F[T5O8^^"KZ$OO^_>K_UP'#`[,%G
MP>/"7\+;PUC#U,11Q,[%2\7(QD;&P\=!Q[_(/<B\R3K)N<HXRK?+-LNVS#7,
MM<TUS;7.-LZVSS?/N-`YT+K1/-&^TC_2P=-$T\;42=3+U4[5T=95UMC77-?@
MV&38Z-ELV?':=MK[VX#<!=R*W1#=EMX<WJ+?*=^OX#;@O>%$X<SB4^+;XV/C
MZ^1SY/SEA.8-YI;G'^>IZ#+HO.E&Z=#J6^KEZW#K^^R&[1'MG.XH[K3O0._,
M\%CPY?%R\?_RC/,9\Z?T-/3"]5#UWO9M]OOWBO@9^*CY./G'^E?ZY_MW_`?\
MF/TI_;K^2_[<_VW____N``Y!9&]B90!D0`````'_VP"$``$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$"`@("`@("`@("`@,#
M`P,#`P,#`P,!`0$!`0$!`0$!`0("`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`__``!$(`#P`K0,!$0`"$0$#
M$0'_W0`$`!;_Q`&B````!@(#`0`````````````'"`8%!`D#"@(!``L!```&
M`P$!`0````````````8%!`,'`@@!"0`*"Q```@$#!`$#`P(#`P,"!@EU`0(#
M!!$%$@8A!Q,B``@Q%$$R(Q4)44(6820S%U)Q@1ABD25#H;'P)C1R"AG!T34G
MX5,V@O&2HD14<T5&-T=C*%565QJRPM+B\F2#=).$9:.SP]/C*3AF\W4J.3I(
M24I865IG:&EJ=G=X>7J%AH>(B8J4E9:7F)F:I*6FIZBIJK2UMK>XN;K$Q<;'
MR,G*U-76U]C9VN3EYN?HZ>KT]?;W^/GZ$0`"`0,"!`0#!00$!`8&!6T!`@,1
M!"$2!3$&`"(305$',F$4<0A"@2.1%5*A8A8S";$DP=%#<O`7X8(T)9)3&&-$
M\:*R)C495#9%9"<*<X.31G3"TN+R565U5C>$A:.SP]/C\RD:E*2TQ-3D])6E
MM<75Y?4H1U=F.':&EJ:VQM;F]F=WAY>GM\?7Y_=(6&AXB)BHN,C8Z/@Y25EI
M>8F9J;G)V>GY*CI*6FIZBIJJNLK:ZOK_V@`,`P$``A$#$0`_`-ISY-?,C=6(
MW)E.KNG:BFQ];AI%H]Q[MJJ9LE-3U\XU)3X:!25FG4?7ZV/OF9]Y'[U^_P"P
M(UAL2:%4T[?#J6!(J"5J!\NIRY%]IXS%!=WT=4D`?2VHT!SFI_P\.BT8KM7Y
M*YT>2#M3=HX^X;[:6E8$)Z6!33Z`6'Z?Q]/>'>W_`'B_>/F%"UHER17R:/UX
M\1U)NX\E<N6D8'T%N#_I.E-+O3Y*0X^.H_TL[Y+5-6%%5XJ?0@-O3^FU@3[%
M\ONO]Z&=07YO0)0?\1(L#R&&\N'SZ*$Y<Y:;2IL+>G^DZ2V7[A^2VV:Z9:SM
M;=4J4ZA[NM/5W!L1=8U_/]/95+[Z_>"VDGZSGJ)6'&MK'Y9/XCT81<@[!=#]
M.RA`/HO1XOBK\L:_M7(U/778L,5!O6BH%K,7DJ.%Z.GS]*!H,H20Z1EU')C'
M!^MO>;WW7/O;CW*EAY;W"+7?+V5JG<PP6P@PQR`3\NH=YZ]NY]FADF5"(JU(
MS@5P1G@/\'5@L1#QZ023P;FX)^@(/]#_`%]Y]NJFX*R\2,#_`(KJ)[=#;UC;
M-#U-X4?G_B;^W.K=5X_,CY_=6_"S?/QGV9OZFJ,C6?(WM"FV)'54U9!2#9&*
ME04<V_MPQR:FJL5!D*JFI"!8&23CW[KW5A*.`OUU`<A@00RD7#`BX(*F_OW7
MNF/-5%70XO(5N/HJS*5=!0U^0I,715"4\N4K((GEBQ,;M>TM0ZA5)L`3S[]U
M[JE?MG^=_L/XVYK%[?\`D_\`$#Y7]'9?.4^4J]N_Q[:^W,YA<Y%B"W\0?#9S
M#YV2FJM,=GL;<$<#GW[KW0A[(_FM;I[8VACNR.FOY=_S9["ZXRM)_$,?NR+:
MNT=OOEJ`W`K\)A\UN>&IS:-H)7Q7+$<#W[KW0F_%/^:Q\4_E?OS)=.;<S^Z^
ML^_<)+64&;Z*[LVY5;![!HZ_%%A645!2Y$)09?)0FS%(97;3?BPO[]U[JS%*
MB(H/5:PY##D'\@@_F_\`O/OW7NB=?*[YW?&+X2;5I-S_`"+[,H]H3Y*\>V=G
MT"MF]_[N<.$6';FR<7YLGD97D.A;)I+<%@??NO=%$VY_,%^9G<V(AW3\>_Y8
MO;U5LW)+]W@]S]^=G;,Z5J\[B7!:.II-IU\63W#C#,@O&)E`-Q^??NO=`1W3
M_.VW3\3:O"XWYD?R_?D7T=#F5A>@WIA=Q[6["V'E*AY%A%%0;DPZI2391==S
M15&F8*+V]^Z]U>-LC=M!OC;&V-ZXN4R87>VVMN[LPL,WHEI<;G<7#E(#-^"_
MCG%_Z-P./?NO=+&IOXKK*8"`2/I<\?I'/ZC_`+'GW[KW5?\`NSY^=9;4^?'6
MOP$JZ&M_T@;_`.J,OV5)NJ7*T]%@=NUU/*W]W]F5%!*1+E,]N.DIIIXEC:_C
ML?\`#W[KW5@<=PL(-P1J!!_J`;C_`&!'OW7NL_OW7NO_T+R</@J[<&]=W5<M
M6S5-1O/.*K3S1HP*95UC8-8-=5%A^;>_F[O]LYWYRYEGANX6:/ZJ494?#XKC
M^+TIUG#-+<6MK$4&?"3R_HCH]77_`%I34T7\?RU)1[7R&"!KLZLT3_W8SF!7
MAJXU)],>:`Y$8L"?Q[Z%>TGMR=DV>`W>VAI=/\"\*?.O4,<T[[?B4KKIGH6\
M1MW8.;QV'I\4]=-C<3G*S(X_+34[FGS$DB%_M\F;!4IXF>RG@:0/<I\M;'R+
MS,LT%MLLI8%A7Q?,$@X`Q_DZ!MUNFZVY5VD-2!CR'V=`3V;U144:5B46/?(Y
MR0O+E]T2@Q[=QD#DO&F*<`1S.J,`?K]/>.OO5["VDLLDMAL]P%))Q*W#C_$.
MAERWS+?NL8+FM1]O$=%[Z$Q4V,^2W76B>"L-7D:]:IA(3ITT#@,`#Q<B_N&/
MNM#;.4_O&[7L49[/%1"*G!(KFOG7CU)GNSNT$NV21@`.8/E_#]G5YT;>/03]
M%!O_`+$V'/ON+<N\N^V\:GM`-?\`>2>L/909IW5>/4IC&9PCFS,I9>;"X!:X
MY_"B_LSZ;ZTI/YJ.VMX_-[8_R5_F%[4JJ]NLOBYV[C/C1T]1HCM3U>QMIY6F
M'9O:J'A/M*OLNMI_%)8,(Z>U^/?NO=;+W\LSY,+\L/A1T5VS45T53NJGVU#L
MCL.4$-X]Z[+2+"YO6"Q/DS0@AK%/UTU`_P!C[KW5@-A)^`"#?C@AOR?]?GW[
MKW6KW_PJ!CC3H#XOLS?NIVYO-5F_W=XVV/4$H)K>01L;76^DV''`]^Z]U=]\
M`V=_@Y\2RA*7Z$ZU8Z!IN1MK%CZ+:Y)//]3]??NO=:I'\[7&28;^;QTO4],T
M-2.X<GC.EL]CJ7;<:QY>;?O][8J2BD1:;3+)DZW;H+.ESYHQ=M7OW7NMN+Y1
M_(;!_%?XX]H?(#>D25=)UQLPY@XZZWS6Y3$E'BL*I1@0U1G)D632=2HQ(_3[
M]U[K6B_DS_'S/_/3Y&=Q_P`R[Y>R3=D[FV=NLXGK&BW+$*S:^*WA/1?Y=+MK
M"O'-3P;3V5A#34E#3HBL\Q\AN1S[KW6WBE.\L>J5R6<7!/\`9U"Y(4W"_P""
M_CW[KW1=_E!\=>OOE5T3V/\`'_LS&09+;78FV\EB@]1'#)+B,S''*V+W105!
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M/?NO=#![]U[K_]&_?9#XH;NW&:NAR+6W3N`@TKI(;C+R$'Z'\^_GOY8@MK*_
MN;873&=K^<_$U<SMYG/\^LRMRB>7:05)KX2^9_A'1Q>W8LG3]'024&,S=%CZ
M3<>)S63Q==GWRE9'B%;R5&5I\53+]Y24:UZJ"LUTL?I;WG1[KQ[COGL=8;/M
M#R)=@HVJ-BKT5E).I"K4QFI^74,;/>QV6^3&XC5WIIJRUI4\*M4'C4#CTX;`
M[YV]C]M_8B>@J(<E1_:I2HR`F:1"NH`<!V+?CF_M%[=^[F[2W=M;OMZ(`JH2
M$B%=("DXS4TK7CZ]&7,/(-A9J98KPDMW4U.>.:9X<?+I<[V-5E=B8*3,8K-5
M;4U.S5^.Q>5@H*/"1G48I:_',1/(&C((+7O?W(7NEO;;KMH=SI(1N&."U\N@
MMMZR6$A$"5X9]?S/1,.HFQS?)OK(TD,]./X]6@?<3QU&H?8/8?L@<'_'WA;[
M%/'-]YWV>954EKN\K@5:EM*1J/G3B*UIQ'4T<RQ:/;>XDD6LAA.3DU)\B:GJ
M[%>7_J#?_'Z$^^V90KNY;Y#_`([UB/$P:P+`]U3_`,>ZKJ_FE_)K*_%OX==G
M[JV9]Q6=K]B-0]+=*XJDT296I[-[-)VUA9<3`/W)WPT50]>`OT,7)`]F73G1
M#>LDW?L3X,4GP2R'\M_Y5Y[;==U)4;.WKN&HBZ^%/N;>>ZJ&2KW/O26<Y]?+
M7/O&=JY=8#(`@8'18^Z]T1K_`(3O]O;GZ8[X^0OP0[,2HV[D*G[_`'?M3:>9
M!6NQ>^-B3C$;SV^8W-HZL8<15DRJ!?[<GD`>_=>ZV]H;^+DW-C<_U-OK_L??
MNO=:O'_"GW[7_0!\6!/#+4TO^F'>.KPDZS_OQZBX4_ZKZV_Q]^Z]UBW5WU_-
M1^'_`/+@Z3[XZDD^.'9/4&$Z7Z^EK,=#L[=4N^NJ-GU6WL=%C=S9J-:V2AW5
M3XYI%&4\:1^%E)L5!;W[KW0G?R4^OOC-\D<;N+YX;KSV?[T^>LV9?#]P;F[.
MJ::KJ.K,O4)+_"*+K7;D:#&[7V7E<$J/054:R2:`P5DT&_NO=&"_G]T>4J/Y
M;F^CAD8TM/V9USD,PHD8,:#^/M))Y;']Q&RLD:D'AKCW[KW2=_X3QSX6?^7K
MCZ#&M"F7QO</8L^Y5IWUF/)5U1`5C9^6.A.%7^S;CW[KW5\H%A;W[KW4<T\-
MKV'Y(-_S]"1_B?S_`%]^Z]UT4O%;3<D$`$?6Z_3D<#W[KW5'W\Z'M+=^5ZWZ
M>^%756'W)O/LCY=]CXC%;JVAL.6!-W2]`['GBW!VC/1U%<8:?'S9JEH?LEJI
M2(F!D0_7W[KW0%?/[,=B_*SX1;S^.F)_ES_)_KZGVE@\9ENK<MDH=BTV-V;4
M=:Q!-NU]50T&9JZA<6<-12Q&E0>5HVL1QS[KW4W_`(3I_)M^T?B]O#X[;@KC
M5;A^.VZ3_=43.175/6N[@^2QL:PMS'_=[<)JZ5^;#7&`./?NO=;&7OW7NO_2
MN\CRM9M3?>[\9-)-CJU=W9RF>CD7]RB\N49UD<GGU*UQ[^;_`'[:-VY6]R?I
M9F;0;IWIG@7=N!/6=&QVXW':\BJ^&HK]JCTZ.QU;VICZ"HI,;15,1CJ(]>\=
MPY4"LJZ_&XK4\N"@BJ?*=4NHW7\@_3WF=[;^\FVW6\VW*VXT9!%D'3D!:TH0
M:\*\.H8W[E]8]PF`H&J2,\#Y'I<XS,]2X>3%;OHMB[.Q^5S>?SF/J<C2EF_N
M^OC+15%'CZA335%0P(=@$`5CQ;V/&YLY/V^Z>2U@16U'@5QGR[>@U<;9S#J1
M;J=R@]:Y'SST#':79D6721<C4H-QT^K'TV:I:AX*7<>+N2K96&)DBB94`%R.
M/<'>\WO%;V]KIAD`4BG$>>/EU(7*FPVQC47`'V=!9\=\CD-S?)?KF>*GAEFI
M*NNR-9+3JD<6.Q<6/=3-($`7FU@Q^OL%?=ON1-]YGV7#,-;W-V0/,UM)3@="
MSW%A^F]LKQCA`K"OYXZO&NS0NZ#5<.9=<_@IU0$^OR'Z63DVX]]VGC"[K$<Y
M'I7RIP\^L)=MD\7:GJ174?\`#Z^G6OWNCM/9?SS_`)S_`%/TIAMV;=W)TM\!
MMFYKN"KI<?E,?5X_=W?>7"X2D@I@)YH,X^QXWU3+&KB!PQ!')]VZ,.MA(3"0
MB0-)X@UF`U7#@BZV^H-_]X]^Z]UI;?S8L?/\#OYNO4?R_P!HYB),;OJ?:?;6
MX\-C9Z05U&FVZR/:6_*6HQ2S1UE4-U8B8RN0"LY!U7(/OW7NMOWJSMOKSNS9
M&![3ZJW;B=Y[$W;C:;(X+/83*15E#41U$22-3-!$Q-#F87?0\,EF5P0P!X]^
MZ]UK9_\`"GS<>"/47QAV:F6Q!W4_8>\LZ^UWK:.7.T^%&U6HCGUH5G6?[..O
MJ$4O;022`?K[]U[JZOX"3[([+_E_?&S$O+@=];4K_C[M':.Z*2D?'Y7$5X7;
M$.'W!@\G1Q22JC2,LBS1GDGZ_4'W[KW6JQO;&]G_`,B3^9)1[GVM39?<'QL[
M.,TU#CF:48W>'1^:RP;,;4K90%A.^.IJIFJ:`%#))311J!H<@^Z]UML;JQW0
M7\P;XK[OVI@=X8#L+J+NS9=1BZ3<VU\A1Y.3%S9-/-AJ]J:!GFQ6<VS6B*22
M.4QRI)!9@I)M[KW6LE_+W[PWY_)F^4G8_P`0/F[CZG9/1G<>XTJ=E=PU,$K;
M'DW50,F,Q.]J?+>B&EVSN7"B..O@6TE-5@.X^M_=>ZW$\#G,1N7$8[/[;R>/
MSVWLO21U>(S>WZVDRV(RV-E6\,]'74\TD$L<@X#HS"X^O!]^Z]T7?Y3?+3H_
MX:]99WM_O?>N'VE@\;C:FHQV#GRE,-P[OR,<,[0X/;&!FE2JR&6FE14:2,-$
MJM=K#GW[KW1=OY;'=7:?<_P^IOD]\D]TT.-A[:W7O;L_;E'7RX_!8/K/J#^,
M5`V3MN6N\D<,L.+PU#Y*BID>\CL=1L/?NO=$E_E[[VVU\[OYE'S#^<N/W%0Y
MO9/26'Q/QD^.F,@RT$X?;4:S5F[]^)BPTLU-3;HRR2+'*-.I6M<_3W[KW5_3
MU$$EH)6$@-X*A:A2(YXY+I)&T5M,EU8\&XM[]U[K2)ZN[`VU_*E_G;=D;-KM
MUX?&]#[OW95;7W1-49B!Z?:NP>VD7=6UURB0NGVTFU-S3B28LNJ*)K&P'OW7
MNMU;^].V_P"[?]]/[V;>_N<:'^+C=QS>)_NI_`0MVJQF?N?L?X<4()G\FB]O
M5;GW[KW7_]/;Y^0?P_Q_:N6_OGLC-TFSMYR,RY9*FC%5CMS(GZ%K-'JIY3:W
MD7U$_7W@Y[W?=/\`;[GVUDGY=O)UWMJFJW$E=1-<:%J,\1J`ZD[E/W(N=F,<
M,VLPK0"GD!Y$$TZ*_0?"[Y%XU*N./(;+4U+,8R<G."I-U+J?'J#,!R1R?S[Q
M'V#[CGNWRW>RW&T;@E"31I5FD8`_TBU>I*F]Z;%D'^Z^-F]3%'_A(Z??]E&^
M1YH:2F>IV<QI)#(NK*3L!(P]4BW0@.WY/U/M>WW./O"LQ)YFV_B>-O<>?^WZ
M9_UX=O)&JP0_;$G^;I@K/A-\@\E5AZRKV/\`;RC_`"H'(U;!1Q]!H^@^IM[8
ME^Y;[^W``GWO:I#_`$[29A_QICU=?>.R3X;)1]D:#HYGQM^,6"Z+AR&9R>67
M=N^<\/MZ_.2TWVZ8V'1I&'VU3Z3X\=S8N_)(Y/X]YU_=O^[/8^T5FE[N,4=Q
MOFDD2."TD+-\;1O(NM`:D`*P.GMX=15S7S;/O"-"99%LZDA"U5:IKW+6@H>`
M_;T*?>'1/7'R(V3)UQV:NXZS;-1DH,F]%M[=69VI6RU6,%_M7RN"J<?6M2-J
M(DC\@5P?>2]I+)#NK^&Q:E0*YICY]1S!1@=/PGR'#]G1/O\`AHG^73C/X>-M
M_'S%[(SN-27(4FYMD;HW5M;=Q>9A)4R3[@Q>?AR]1)4R>J766$AN6O[,>GNK
M$*3:U#1;9H]I4\E0N!IL(NVD,M;4R9-\2,8,<L<E>9#4OD[`$SEC*7&J^KW[
MKW5>W_#0O\OK)Y.;,[QZ!H^PMR,)0-P]C;NWAO/<-/#-(T[P4E?D\U,::F9W
MOXHR%_P]^Z]T)?3/\N?XD?'7=&5W9T9UM7=:5F9P>5V_D</MG>6Z:7:IHLZC
M1Y&:FVW4Y:JPU/EH5)*5$<*3QD^E@??NO=!A!_*`_EZ29(9S<OQ^H^R,ZT=0
MM-G.S-U[PWOE::*HD::>&CJ,QGZB:EII9&NT<85&XN.![]U[H1>F_P"7%\0_
MCKV%C>R>CNM<GUIG\2V56EPNW-Z;KI=FR/FJ8K7:]J5F7JL!*8X^4/@!0FX]
M^Z]T*GR+^)OQY^7&V<!L_P"0_76([.PVTLVFY<'19:2JI\EALXUT>H6HQE33
MU,,%1&0'75XW4`$$`>_=>Z"[JW^6O\..B]_8'LKI?JE^JL_M^:6KI:/96[-U
M8C;4\DU&:.1\GM3^+RX+(/+J)8RT[$N2Q-R??NO=&)[GZ`Z8^0VU)=D][]8[
M.[4VC5+)_N&WC@Z/,?:-*H$IHZMU6HHFDL+M"\;&PYX'OW7NB+X#^4K\=>O8
M9L=TEV1\G.C-MU*,HV'UKWEN>BV721$W$>,P69.47&Q@_18)46WX]^Z]TY4_
M\HCX-9#</]ZNT^N-P?(W>9HS1_WE[_W_`+J[(R%.MAY&QM'E<C%B,<SB_,$"
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MUVO\HGX+)M6?88ZUW7_<"=Z4R=?'M/L4[-\-)]YX:%<,=P^!,;:MDU0`"%N+
MJ=(M[KW7_]3?O5&%^$`)_LK;_7O_`*_M*I@4U%B5/K1>G`(U%%!ZXRK;FR?Z
MY4?G_'WZ9=R<_P"*3QJ/Z0)_P'K6A9?B+?D>N6F3^@Y_P_XW[KXGK!-7[?\`
M9ZMV?Q']O6'QG_5?[S_QOWOQ#_RC3_M_V>M]GS_;US\`)#*$N`5#:!=5_*@V
MN%_P]N7$MX.R(]I_U9SQZ2&-G/>YZ;:Z2FH*>:MK9A345!!6UM;5-PD4,2ZW
MY/T(C!/^M[K#X5A&\UPPU'S/5U`B!)ZKI^-O9&PJ7>>[MV[DS]?1;G[OWSDZ
M?KC$9*3)96GPNR<1-]MAJ-,H7EH**KS-8'J!2EDJ&CMZ2M[*>.>K=&K[[WWL
M+;VPLYA]\[NR6T*?=,=-M^'*;76:;<M&^8K1C8*^DAIE>HI9/N7%I5`9/K]1
M[]U[I7+D-O\`4'76.BW#NVH;#;3PM%0UNZMR3R5&6KI(XU_AQE5KRY/,5S<>
M-;R.Q^A)M[]U[J1L7LS;/8O\5&UZR<56!GI(<YALE0RXS+XQ\E2"NQDE31U"
MI)&:R$ZE)'J4GW[KW0%;]^46TM@=LP['GH17[4Q6T\GNGL?>V-CJ\FFPJB+(
M)!BZ3*QTHD^V2IJI'E:XL(E^EA[]U[HQ]7NO!1;2K=YU-;3S[9BVY-N)LW!,
M%IZO;W\+?(+6TKJX56DA(L1SR/?NO=$/^)O8^Q-B[0P<>\MU99-Z=X[MS6X<
M0V8&3RT.+^\JW@P6V:K.2^:C@RTF+"RI2>2YU7TBW/NO=6!9/.8_`451D,ID
MZ.CI*201U%?6310QRRD-HH(V=U!JV;A5'J)X`Y]^Z]T'^U.X=E;WW3N/96V*
MZHR.<VECL?D-PF?&U-'C<8,M=H(IZBI72N3T\F#ZA>?I[]U[I-9_Y-]-[7J]
MVXW*[K#5^P\3'D]Q45!BZ^NF2ADTK]QB8Z:!SF0CFS&F\FGF]O?NO=*_+]M;
M)P6QJ3L;,9[[+9U7BHLW1U[TE2*VM@=16`TV+"-6'_)SR-/'YX]^Z]TCZ7Y-
M=.5F5VMB4W8IGWIB/XYMB<4-1_#*V,@M]K'5A2DF9M?_`";EK_CW[KW2WZ[[
M5V;VEALEG=E9.7(4.)R]?@LJU1CZK'UN/RN+;QU=//1U"1R(WU^H%[CW[KW4
M+?W<.PNLL=E\CO'<5)BTPV/2ORZP4]1DJO'4$K*F-ER=/`KM0_=M(`A<*'8_
MT]^Z]TM\-FX,[AL/F:-*S[;,TN/KJ&"NIWIZ]H9D#AJ^G=?\D+(P/T'OW7NE
M5I6]]*W_`*V%_?NO=?_5W^/?NO==$`_4`_ZXO[]6G#KU2.!Z[]^Z]UU8?T'^
MV][J?7KW7%_T\<7/XX_!]ZZ]T4SYA9K<.!Z)W'!M<5T<FX:_![5R>8Q]'5Y>
M7;&W<ID$AS&;BH*77654E)3%Q<`F[?BP]Z95<4=0P^>>O=!]UMU51;BJ>LJ7
M;N'GVUT9T[+%G]LUV5HI:3='9F]HXEC3<U;231>:CP-(KN4>514NW`TI8+OK
MW43M09#L/Y*[`V)#M',9';_7E-0[YW+D*'&_:XO=>Y\C+IP.,R^:J8GB_NQA
M*>]?+%$Q8U"A"/?NO=/_`,F*&.J[5^/&7WO#DJGJ/:F;S>[LTV-H:K)42;WP
MF-,NTER-!1Q3SU-)-,["-75D+\_U]^Z]T^_';;VY8\OW#W_V+25>VZSM;-TN
M4Q&`R[JL^U^NMJ8]J3"296.+T1U53CXS*2PUH+#Z'W[KW1/]IYBM[+V)\A)-
ME[?KY^TOE3O;(X3;^*J<.]/CL#U;0/)MZCW7F\J(UHFV\^-DK)0T;>9GD2P)
MN1[KW1I>^-J[AV_\?>O_`(^]?C(5F5WI4;(Z;?.4M"9Z7%[2@IHH=T9W(NH:
M.AH_X)031!S:\LJ\^_=>Z3FW-I[3[-S74&S^O-O97$],]`YVNW#E\IEL968G
M)9C?^UFDV_C,-!!71Q-E%(:>JJZM@VM&3Q-:UO=>ZP]M]CYJ/N_=F%K=GYW=
MF-ZTV*V[=A[4I</,VU-T[MJXS45NX=U9#PM!--MJF'AHZ9;O+(2RV?GW[KW2
MY^(V/RL/6>4W3NS'Y)MS=E9W([_W3ELO1BB;/UF365Y:#%XR7174E+BX8O'#
M%*!H^B@`^_=>Z9?C9UY)F-X]H]];NV^^,J=Y9N3`=>;=RF.2&;:W7>$9H:5!
MBGC\='/D""SE%!8?6]_?NO=._P`G\=G]^C8G0NT\164<_8F09MT;UI:!#1;$
MZZPP!S$M-6:5BH<MFH@(:>)&0V)'TM[]U[HLV>I)=N2[T[JH>NLM3[.^/F.3
MJ7XU[-FPT]6V1W7*4H\OVCD<9!`)JJ*.:35#-*A:RDW!Y]^Z]T:#85'G.F/C
M#F<KB]LYO*;RQ6"S.\:J'(JLV:WGO#-:<P<[5Q1ZIWF-9,5%,P-TC"6^GOW7
MNBE3G)[VFZ4V!)M'?N6VYV/)2]K=M;HS>!JZ'</9^YL0RU:[(K:AW";>VU0Y
M0#]BH80:(@JH.2WNO=6[TNLPP2O!'%-)&HE15`,8`],5_KIC^G]/?NO=2_?N
MO=?_UM_CW[KW7O?NO=>]^Z]U[W[KW71M^;?['W[KW45]//CT>35ZK>/5X=1U
M:M7^ZM5[_B_^/OW7NN+VU^OR:N;?ZW%[6XT_UMQ[]U[K,;Z.?T_X_7Z_[?Z^
M_=>ZB^C\^+_.)^OQV\MOV_U\>2WT_-O?NO=%V^5O\<_T%]J_W6^_^Z_N3F/X
MQ_!/M/XU_"/MF^\_A_WG[7G^Q\MK\:+^_=>Z6G3/]W?]$'6?]T/#_=W_`$=;
M:_@WC^T\_P!A_#*+5Y?'Z/\`.W\NG]OR7]^Z]T*:VN]KZ?$VJ^GQ^._J^O\`
M9O\`6WOW7NNO]W4WEO?6NG5X]/E\?%]/'F\7^QT_X>_=>ZS2VU\Z+:H/^.7U
M\A^VU?VK>7]%^-7T]^Z]UQ?1Y6UZ?/;]N^CR:;#5X?[7TM>W^Q]^Z]UGCT^9
MM>CSZ>?T^31Q;Z<Z;_["_OW7NNY;>O3IOZ?+;3J^AMKMS]/I?\>_=>ZQ'5]V
M;W_X"MIOIT6U+JM_CJM?\6M[]U[KP^DNJ_EU1VU:=?\`G#HTW_LWO;W[KW6*
M31HG\_\`F_*VO5X_'XK^O5_S:U_J_P!J^OY]^Z]U/C_2/ZV%_P"O^%_S[]U[
'KG[]U[K_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
